Therapeutic Adherence in Patients With Chronic Diseases

Completed

• Conditions: Chronic Disease

• Registration Number: NCT06573619
• Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Brief Summary

Objectives of the study are:

* The validation of the GMAS questionnaire in patients with chronic disease.

* Measurement of the level of therapeutic adherence in patients with chronic illness.

* Measurement of the level of therapeutic adherence in patients with chronic disease undergoing an experimental trial.

Detailed Description

The research is multicentre and will be conducted at the Fondazione Policlinico Gemelli IRCCS in Rome as reference centre together with the other participating centres. Patients will be enrolled at the centres involved, either during visits or during their hospital stay.

Study Timeline

• Study First Submitted: 2024-01-02
• Study Start: 2024-01-08
• Study First Submitted QC: 2024-08-23
• Study First Posted: 2024-08-27
• Primary Completion: 2024-08-31
• Study Completion: 2024-12-31
• Status Verified: 2025-03
• Last Update Submitted: 2025-03-10
• Last Update Posted: 2025-03-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

• Chronically ill;
• Age 18 years or older;
• Willingness to participate in the study;
• Chronic illness diagnosed at least 3 months before the start of the study;
• Reading and signing the informed consent.

Exclusion Criteria

• Reduced command of the Italian language;
• Subjects suffering from severe psychiatric disorders;
• Serious clinical conditions that do not permit completion of the questionnaire;
• Refusal to sign the informed consent to participate in the study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The validation of the GMAS questionnaire in patients with chronic disease.	1 year	The validation of the GMAS questionnaire in patients with chronic disease.

Secondary Outcome Measures

Name	Time	Method
Measurement of the level of therapeutic adherence in patients with chronic illness. Measurement of the level of therapeutic adherence in patients with chronic disease undergoing an experimental trial.	1 year	Measurement of the level of therapeutic adherence in patients with chronic illness.; Measurement of the level of therapeutic adherence in patients with chronic disease undergoing an experimental trial.

Trial Locations

Locations (1)

Daniele Napolitano; 🇮🇹 Rome, Italy